Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
***ALERT*** <<<FOGC>>> MUST READ !
MILFORD, Pa., June 30, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that the company has initiated filing for a voluntary name and symbol change with FINRA and the state of Wyoming. The change to Manzo Pharmaceuticals was filed with the state already and the company is in the process of providing FINRA the necessary documents to get it approved. The process has a 60 day deadline, but Manzo Pharmaceuticals feels it will be completed much sooner than that. The company has also put together a strategy to improve the share structure in an effort to get Manzo Pharmaceuticals off ground and moving along the way the company should be.
With the help of market consultants, Manzo is also in the process of laying out a complete strategy to decrease the number of outstanding shares, and even more importantly, the float. This strategy will include buying back blocks of restricted and free trading stock held by former affiliates, as well as buying back shares in the open market. The company is also examining several traditional methods of raising a block of funding to allot to this cause including several types of registrations and offerings that will not unnecessarily dilute the float, which would be counter productive to its cause. He explains, "I want everyone to know that shareholder value is very important to me, and I will do whatever I can to increase the value of this company for its shareholders to the level it really should be."
Overall the company is focusing on its strategy for the next twelve months in all areas of the business, not just the marketing and release of new products, but the reduction of shares resulting from past dilution and whatever else it takes to help Manzo Pharmaceuticals provide shareholder value, while bringing much needed remedies and treatments to the people who need them.
***ALERT*** <<<FOGC>>> MUST READ !
MILFORD, Pa., June 30, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that the company has initiated filing for a voluntary name and symbol change with FINRA and the state of Wyoming. The change to Manzo Pharmaceuticals was filed with the state already and the company is in the process of providing FINRA the necessary documents to get it approved. The process has a 60 day deadline, but Manzo Pharmaceuticals feels it will be completed much sooner than that. The company has also put together a strategy to improve the share structure in an effort to get Manzo Pharmaceuticals off ground and moving along the way the company should be.
With the help of market consultants, Manzo is also in the process of laying out a complete strategy to decrease the number of outstanding shares, and even more importantly, the float. This strategy will include buying back blocks of restricted and free trading stock held by former affiliates, as well as buying back shares in the open market. The company is also examining several traditional methods of raising a block of funding to allot to this cause including several types of registrations and offerings that will not unnecessarily dilute the float, which would be counter productive to its cause. He explains, "I want everyone to know that shareholder value is very important to me, and I will do whatever I can to increase the value of this company for its shareholders to the level it really should be."
Overall the company is focusing on its strategy for the next twelve months in all areas of the business, not just the marketing and release of new products, but the reduction of shares resulting from past dilution and whatever else it takes to help Manzo Pharmaceuticals provide shareholder value, while bringing much needed remedies and treatments to the people who need them.
Fortune Oil and Gas announces name change and plans to improve share structure
MILFORD, Pa., June 30, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that the company has initiated filing for a voluntary name and symbol change with FINRA and the state of Wyoming. The change to Manzo Pharmaceuticals was filed with the state already and the company is in the process of providing FINRA the necessary documents to get it approved. The process has a 60 day deadline, but Manzo Pharmaceuticals feels it will be completed much sooner than that. The company has also put together a strategy to improve the share structure in an effort to get Manzo Pharmaceuticals off ground and moving along the way the company should be.
With the help of market consultants, Manzo is also in the process of laying out a complete strategy to decrease the number of outstanding shares, and even more importantly, the float. This strategy will include buying back blocks of restricted and free trading stock held by former affiliates, as well as buying back shares in the open market. The company is also examining several traditional methods of raising a block of funding to allot to this cause including several types of registrations and offerings that will not unnecessarily dilute the float, which would be counter productive to its cause. He explains, "I want everyone to know that shareholder value is very important to me, and I will do whatever I can to increase the value of this company for its shareholders to the level it really should be."
Overall the company is focusing on its strategy for the next twelve months in all areas of the business, not just the marketing and release of new products, but the reduction of shares resulting from past dilution and whatever else it takes to help Manzo Pharmaceuticals provide shareholder value, while bringing much needed remedies and treatments to the people who need them.
About Fortune Oil & Gas, Inc.
Fortune Oil & Gas, Inc. owns and operates Manzo Pharmaceuticals, a specialty pharmaceutical company engaged in the research, development, and testing of patented and non-patented solutions and remedies. Most notably is a patented solution for lactose Intolerance, and a natural remedy for colic in babies. For more information follow the company on twitter at @manzopharma, and visit www.manzopharma.com.
DISCLAIMER: ?This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.
SOURCE Fortune Oil & Gas, Inc.
Copyright 2014 PR Newswire
***FOGC*** Fortune Oil and Gas announces name change and plans to improve share structure
MILFORD, Pa., June 30, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that the company has initiated filing for a voluntary name and symbol change with FINRA and the state of Wyoming. The change to Manzo Pharmaceuticals was filed with the state already and the company is in the process of providing FINRA the necessary documents to get it approved. The process has a 60 day deadline, but Manzo Pharmaceuticals feels it will be completed much sooner than that. The company has also put together a strategy to improve the share structure in an effort to get Manzo Pharmaceuticals off ground and moving along the way the company should be.
With the help of market consultants, Manzo is also in the process of laying out a complete strategy to decrease the number of outstanding shares, and even more importantly, the float. This strategy will include buying back blocks of restricted and free trading stock held by former affiliates, as well as buying back shares in the open market. The company is also examining several traditional methods of raising a block of funding to allot to this cause including several types of registrations and offerings that will not unnecessarily dilute the float, which would be counter productive to its cause. He explains, "I want everyone to know that shareholder value is very important to me, and I will do whatever I can to increase the value of this company for its shareholders to the level it really should be."
Overall the company is focusing on its strategy for the next twelve months in all areas of the business, not just the marketing and release of new products, but the reduction of shares resulting from past dilution and whatever else it takes to help Manzo Pharmaceuticals provide shareholder value, while bringing much needed remedies and treatments to the people who need them.
About Fortune Oil & Gas, Inc.
Fortune Oil & Gas, Inc. owns and operates Manzo Pharmaceuticals, a specialty pharmaceutical company engaged in the research, development, and testing of patented and non-patented solutions and remedies. Most notably is a patented solution for lactose Intolerance, and a natural remedy for colic in babies. For more information follow the company on twitter at @manzopharma, and visit www.manzopharma.com.
DISCLAIMER: ?This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.
SOURCE Fortune Oil & Gas, Inc.
Copyright 2014 PR Newswire
***** FOGC ***** Fortune Oil and Gas announces name change and plans to improve share structure
MILFORD, Pa., June 30, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that the company has initiated filing for a voluntary name and symbol change with FINRA and the state of Wyoming. The change to Manzo Pharmaceuticals was filed with the state already and the company is in the process of providing FINRA the necessary documents to get it approved. The process has a 60 day deadline, but Manzo Pharmaceuticals feels it will be completed much sooner than that. The company has also put together a strategy to improve the share structure in an effort to get Manzo Pharmaceuticals off ground and moving along the way the company should be.
With the help of market consultants, Manzo is also in the process of laying out a complete strategy to decrease the number of outstanding shares, and even more importantly, the float. This strategy will include buying back blocks of restricted and free trading stock held by former affiliates, as well as buying back shares in the open market. The company is also examining several traditional methods of raising a block of funding to allot to this cause including several types of registrations and offerings that will not unnecessarily dilute the float, which would be counter productive to its cause. He explains, "I want everyone to know that shareholder value is very important to me, and I will do whatever I can to increase the value of this company for its shareholders to the level it really should be."
Overall the company is focusing on its strategy for the next twelve months in all areas of the business, not just the marketing and release of new products, but the reduction of shares resulting from past dilution and whatever else it takes to help Manzo Pharmaceuticals provide shareholder value, while bringing much needed remedies and treatments to the people who need them.
About Fortune Oil & Gas, Inc.
Fortune Oil & Gas, Inc. owns and operates Manzo Pharmaceuticals, a specialty pharmaceutical company engaged in the research, development, and testing of patented and non-patented solutions and remedies. Most notably is a patented solution for lactose Intolerance, and a natural remedy for colic in babies. For more information follow the company on twitter at @manzopharma, and visit www.manzopharma.com.
DISCLAIMER: ?This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.
SOURCE Fortune Oil & Gas, Inc.
Copyright 2014 PR Newswire
PENNY RUNNER OVER THE NEXT SEVERAL MONTHS IMO
KRFG LOOKS SO GOOOOOOD L2 IS HOT
GOOD INFORMATION TRUMPZ ALL IMO WEEEEEEEEE
Yes yes way to go --- THATS HOW ITZ DONE BABY .....
The CLAP sux ........ trust me lol
Who knows for sure.... MY SPECULATION 003 TO 005 ~ MAYBE HIGHER LONGER TERM
FOGC SAWEEEET DAY HEHE WEEEEEEEE
FOGC SAWEEEET DAY HEHE WEEEEEEEE
YUUUUUPPPPP LOOKS LIKE SOME LYING TO GET CHEAP SHARES LOLZ
***TRIPZ WILL BE HISTORY SOOOOOOON***
XPLOSIVE RUN SETTING UP .... DONT GET LEFT BEHIND ...... HEHE
Lol tick tock
HOLDING EVERY SHARE FOR MONTHS ... BOUGHT MORE TODAY
9s fallin. 002 will come shortly....
ACCUMULATION PHASE ALMOST COMPLETE
Lol. Watch n learn friend. Tick tock
TRIP WILL BE HISTORY SOOOOOOON
BUY BACK WEEEEEEEEEEEEEEE
Oops lmao wrong reply hahahaha
Way ta be disciplined (:
Weeeeeeeeeeeeee
Steady newz flow for monthz to come.... I'm feelin....
Whoaaaaa triple post. Whooooopz
Way ta be disciplined (:
Way ta be disciplined (:
Way ta be disciplined (:
SWEEEEETNESSSSSSS
THOSE 4 INGREDIENTS WILL CATAPULT DIS
SIPC = $$$$$$$$$$$$
<<<<<FOGC>>>>> new ticker coming ...... huge merger
<<<<<FOGC>>>>> new ticker coming ...... huge merger
***FOGC*** ON NEWS WATCH!
***FOGC*** ON NEWS WATCH!
MORNING >>>>> LETZ HAVE A NICE WEEK
$10,000 ÷ .0006 = 16,666,666 x .01 = $166,666
Just sayin
***FOGC*** DEAL WITH GERBER WOULD BE HUGE!!
***FOGC*** DEAL WITH GERBER WOULD BE HUGE!!